Merck KGaA Receives Refuse to File Letter from FDA on Cladribine Tablets New Drug Application
- Details
- Category: Merck Group
![Merck KGaA Merck KGaA](http://www.worldpharmanews.com/images/stories/logo/merck_kgaa.gif)
Pfizer And Protalix Enter Into Agreement To Develop And Commercialize Gaucher's Disease Treatment
- Details
- Category: Pfizer
![Pfizer Pfizer](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
"Positive Charge" to Help Address Barriers and Provide Support to People Living with HIV/AIDS
- Details
- Category: Bristol-Myers Squibb
![Bristol-Myers Squibb Company Bristol-Myers Squibb Company](http://www.worldpharmanews.com/images/stories/logo/bms.gif)
Bayer Starts Phase III Trial with Florbetaben
- Details
- Category: Bayer
![The Bayer Group The Bayer Group](http://www.worldpharmanews.com/images/stories/logo/bayer.gif)
Bayer starts pivotal Phase III trial with Florbetaben
- Details
- Category: Bayer
![The Bayer Group The Bayer Group](http://www.worldpharmanews.com/images/stories/logo/bayer.gif)
Novartis gains rights to two oral targeted investigational therapies
- Details
- Category: Novartis
![Novartis Novartis](http://www.worldpharmanews.com/images/stories/logo/novartis_b.gif)
Lundbeck initiates clinical phase II trials with Lu AE58054
- Details
- Category: Lundbeck
![H. Lundbeck A/S H. Lundbeck A/S](http://www.worldpharmanews.com/images/stories/logo/lundbeck.gif)
More Pharma News ...
- FDA Grants IBsolvMIR Orphan Drug designation in the treatment of diabetes patients in the U.S.
- Novartis inaugurates large-scale US based cell-culture influenza vaccine manufacturing facility
- Merck KGaA to Expand Research and Development Presence in China
- Merck Receives CHMP Positive Opinion for New Fertility Treatment, ELONVA®
- FDA Advisory Committee Finds Data Support SPIRIVA® HandiHaler®
- AstraZeneca Submits US New Drug Application for Brilinta (Ticagrelor)
- GSK and Nabi announce agreement for NicVAX®, a vaccine for nicotine addiction